Literature DB >> 8522716

Optimal electrode position for transvenous defibrillation: a prospective randomized study.

K C Stajduhar1, G Y Ott, J Kron, J H McAnulty, R P Oliver, B T Reynolds, S W Adler, B D Halperin.   

Abstract

OBJECTIVES: This study was performed to determine the optimal position for the proximal electrode in a two-electrode transvenous defibrillation system.
BACKGROUND: Minimizing the energy required to defibrillate the heart has several potential advantages. Despite the increased use of two-electrode transvenous defibrillation systems, the optimal position for the proximal electrode has not been systematically evaluated.
METHODS: Defibrillation thresholds were determined twice in random sequence in 16 patients undergoing implantation of a two-lead transvenous defibrillation system; once with the proximal electrode at the right atrial-superior vena cava junction (superior vena cava position) and once with the proximal electrode in the left subclavian-innominate vein (innominate vein position).
RESULTS: The mean (+/- SD) defibrillation threshold with the proximal electrode in the innominate vein position was significantly lower than with the electrode in the superior vena cava position (13.4 +/- 5.7 J vs. 16.3 +/- 6.6 J, p = 0.04). Defibrillation threshold with the proximal electrode in the innominate vein position was lower or equal to that achieved in the superior vena cava position in 75% of patients. In patients with normal heart size (cardiothoracic ratio < or = 0.55), the improvement in defibrillation threshold with the proximal electrode in the innominate vein position was more significant than in patients with an enlarged heart (innominate vein 13.0 +/- 6.5 J vs. superior vena cava 17.9 +/- 5.1 J, p < 0.01). In patients with an enlarged heart, no difference between the two sites was observed (innominate vein 13.9 +/- 4.5 J vs. superior vena cava 13.6 +/- 8.3 J, p = NS).
CONCLUSIONS: During implantation of a two-lead transvenous defibrillation system, positioning the proximal defibrillation electrode in the subclavian-innominate vein will lower defibrillation energy requirements in the majority of patients.

Entities:  

Mesh:

Year:  1996        PMID: 8522716     DOI: 10.1016/0735-1097(95)00380-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  4 in total

1.  The higher likelihood of developing cardiomegaly during follow-up in patients with syndrome X and abnormal thallium-201 myocardial perfusion SPECT.

Authors:  S S Sun; J L Huang; S C Tsai; Y J Ho; C H Kao
Journal:  Int J Cardiovasc Imaging       Date:  2001-08       Impact factor: 2.357

Review 2.  Dual- versus single-coil implantable defibrillator leads: review of the literature.

Authors:  Jörg Neuzner; Jörg Carlsson
Journal:  Clin Res Cardiol       Date:  2012-01-10       Impact factor: 5.460

3.  A systematic evaluation of conventional and novel transvenous pathways for defibrillation.

Authors:  P R Roberts; S Allen; D C Smith; J F Urban; D E Euler; R W Dahl; M J Kallok; J M Morgan
Journal:  J Interv Card Electrophysiol       Date:  1999-10       Impact factor: 1.900

4.  [Influence of waveform and configuration of electrodes on the defibrillation threshold of implantable cardioverter-defibrillators].

Authors:  M Block; D Hammel; G Breithardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.